Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening
- 19 September 2020
- journal article
- letter
- Published by Elsevier BV in Journal of Infection
- Vol. 81 (6), e10-e12
- https://doi.org/10.1016/j.jinf.2020.09.021
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Are children less susceptible to COVID-19?Journal of Microbiology, Immunology and Infection, 2020
- Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)The Journal of Pathology, 2020
- The SARS-CoV-2 seroprevalence is the key factor for deconfinement in FranceJournal of Infection, 2020
- Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptorPharmacological Research, 2020
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive studyThe Lancet, 2020
- MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015Emerging Infectious Diseases, 2017
- Epidemiology of human coronavirus NL63 infection among hospitalized patients with pneumonia in TaiwanJournal of Microbiology, Immunology and Infection, 2015